288 related articles for article (PubMed ID: 3501504)
1. Complement activation and leucopenia on cellulosic haemodialyzers: influence of the membrane area and role of hydroxyl moieties.
Goldman M; Lietaer N; Lambert P; Thayse C; Vanherweghem JL
Life Support Syst; 1987; 5(4):317-22. PubMed ID: 3501504
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
Germin Petrović D
Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
[TBL] [Abstract][Full Text] [Related]
3. Leucopenia, hypoxia and complement activation in haemodialysis. Three unrelated phenomena.
de Vinuesa SG; Resano M; Luño J; Gonzalez C; Barril G; Junco E; Valderrabano F
Proc Eur Dial Transplant Assoc; 1983; 19():159-67. PubMed ID: 6878230
[TBL] [Abstract][Full Text] [Related]
4. A clinical study on different cellulosic dialysis membranes.
Falkenhagen D; Bosch T; Brown GS; Schmidt B; Holtz M; Baurmeister U; Gurland H; Klinkmann H
Nephrol Dial Transplant; 1987; 2(6):537-45. PubMed ID: 3126455
[TBL] [Abstract][Full Text] [Related]
5. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
[TBL] [Abstract][Full Text] [Related]
6. Haemodialysis-induced leucopenia and activation of complement: effects of different membranes.
Aljama P; Bird PA; Ward MK; Feest TG; Walker W; Tanboga H; Sussman M; Kerr DN
Proc Eur Dial Transplant Assoc; 1978; 15():144-53. PubMed ID: 740661
[TBL] [Abstract][Full Text] [Related]
7. Blood-membrane interaction: C3a, an indicator of biocompatibility.
Ivanovich P; Hammerschmidt DE; Chenoweth D; Klinkmann H; Vidovic D
Life Support Syst; 1985; 3 Suppl 1():394-403. PubMed ID: 3879953
[TBL] [Abstract][Full Text] [Related]
8. Blood-membrane interactions during haemodialysis with cellulose and synthetic membranes.
Woffindin C; Hoenich NA
Biomaterials; 1988 Jan; 9(1):53-7. PubMed ID: 3126842
[TBL] [Abstract][Full Text] [Related]
9. Biocompatibility of hemodialysis membranes: evaluation in an ovine model.
Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J
J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo biocompatibility of substituted cellulose and synthetic membranes.
Mandolfo S; Tetta C; David S; Gervasio R; Ognibene D; Wratten ML; Tessore E; Imbasciati E
Int J Artif Organs; 1997 Nov; 20(11):603-9. PubMed ID: 9464869
[TBL] [Abstract][Full Text] [Related]
11. Abnormal leucocyte locomotion induced by haemodialysis membranes. A clue to dialysis leucopenia.
Losito A; Buoncristiani U; Cecchini C
J Clin Lab Immunol; 1983 Feb; 10(2):87-90. PubMed ID: 6601717
[TBL] [Abstract][Full Text] [Related]
12. Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan.
Schaefer RM; Hörl WH; Kokot K; Heidland A
Blood Purif; 1987; 5(4):262-7. PubMed ID: 3426830
[TBL] [Abstract][Full Text] [Related]
13. Role of protein adsorption on haemodialysis-induced complement activation and neutrophil defects.
Neveceral P; Markert M; Wauters JP
Nephrol Dial Transplant; 1995; 10(3):372-6. PubMed ID: 7792033
[TBL] [Abstract][Full Text] [Related]
14. Complement activation and hypersensitivity reactions to dialysis membranes.
Hakim RM; Breillatt J; Lazarus JM; Port FK
N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
[TBL] [Abstract][Full Text] [Related]
15. Complement activation in haemodialysis: a comparison of new and re-used dialysers.
Levett DL; Woffindin C; Bird AG; Hoenich NA; Ward MK; Kerr DN
Int J Artif Organs; 1986 Mar; 9(2):97-104. PubMed ID: 3699916
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility and performance of a modified cellulosic and a synthetic high flux dialyzer. A randomized crossover comparison between cellulose triacetate and polysulphon.
Grooteman MP; Nubé MJ; van Limbeek J; van Houte AJ; Daha MR; van Geelen JA
ASAIO J; 1995; 41(2):215-20. PubMed ID: 7640431
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo model of hemodialysis membrane biocompatibility.
Spencer PC; Schmidt B; Samtleben W; Bosch T; Gurland HJ
Trans Am Soc Artif Intern Organs; 1985; 31():495-8. PubMed ID: 3879781
[No Abstract] [Full Text] [Related]
18. Biocompatibility of dialysis membranes: a comparative study.
Martin-Malo A; Castillo D; Castro M; Pérez R; Rios A; Jaraba M; Aljama P
Nephrol Dial Transplant; 1991; 6 Suppl 2():55-8. PubMed ID: 1866069
[TBL] [Abstract][Full Text] [Related]
19. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination].
Orłowski A; Szepietowski T
Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility of hemodialysis using cuprophane membranes.
Rommes JH; Sangster B; Borst C; Daha MR; van Heijst NP
Vet Hum Toxicol; 1987 Aug; 29(4):293-9. PubMed ID: 3629907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
